Skip to main content

Table 3 Fatigue ratings.

From: Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis

  Baseline On treatment Mean Change p
MFIS Total score (n = 220) 34.6 ± 18.7 27.0 ± 18.6 -7.6 ± 16.4 p ≤ 0.001
   Physical dimension score 17.6 ± 9.1 13.5 ± 9.0 -4.1 ± 8.1 p ≤ 0.001
   Cognitive dimension score 13.9 ± 9.2 11.2 ± 8.6 2.7 ± 8.0 p ≤ 0.001
   Psycho-social dimension score 3.1 ± 2.1 2.4 ± 2.0 -0.7 ± 2.0 p ≤ 0.001
VAS score (n = 198) 4.47 ± 2.53 3.43 ± 2.55 -1.04 ± 2.88 p ≤ 0.001
  1. Fatigue over three months was measured with the Modified Fatigue Impact Scale (MFIS) and with a visual analogue scale (VAS). Data are presented as mean ± SD for those patients providing exploitable data both at inclusion and at study end. Probabilities were calculated with the Wilcoxon rank test.